Loading...
XKRX
214150
Market cap2.14bUSD
Jul 10, Last price  
48,500.00KRW
1D
-3.19%
1Q
-10.52%
IPO
950.92%
Name

Classys Inc

Chart & Performance

D1W1MN
XKRX:214150 chart
P/E
23.68
P/S
9.28
EPS
2,047.85
Div Yield, %
0.51%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
34.52%
Revenues
336.80b
+38.64%
81,133,256,55076,460,932,000100,596,936,000141,803,242,000180,122,798,000242,938,965,000336,800,000,000
Net income
131.90b
+34.76%
33,393,938,58938,164,823,00043,804,676,00075,378,647,00074,225,203,00097,875,278,000131,900,000,000
CFO
114.13b
+11.02%
39,033,740,00038,125,168,00036,367,042,00054,754,505,00064,631,972,000102,800,407,000114,131,128,000
Dividend
Dec 29, 2025257 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CLASSYS Inc. is a global supplier of sophisticated medical aesthetic devices. Its diverse product range features SCIZER, a non-invasive solution for subcutaneous fat reduction; ULTRAFORMER MPT, which employs focused ultrasound stimulation for skin tissue coagulation to achieve eyebrow lifts; and ULTRAFORMER III, a high-intensity focused ultrasound (HIFU) surgical device designed for tissue coagulation, aiding in eyelid lifting, skin tightening, and improving subcutaneous tissue elasticity across the face (cheeks), abdomen, and thighs, while also diminishing crow's feet, laugh lines, and neck wrinkles. Additional offerings include INTRASURE, a versatile multi-platform solution for aesthetics and healthcare; FORSHAPE, an RF treatment system engineered to boost metabolism, enhance blood circulation, and facilitate tissue recovery; and VOLNEWMER, a monopolar radiofrequency therapeutic equipment used for skin tissue coagulation as a general electrosurgical instrument. The company's portfolio further encompasses CLATUU Alpha, a medical device that progressively reduces subcutaneous fat layers, particularly in areas of excessive accumulation, using low-temperature energy and negative pressure; Ulfit, which utilizes HIFU energy to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device combining RF and negative pressure to elevate tissue temperature and blood flow, thereby alleviating pain in treated areas; AQUAPURE, equipped with four distinct handpieces for applications such as acne suction and various forms of pain relief, including muscle pain; and AQUAPURE II, a multi-functional device for comprehensive facial and body care. These products are marketed under the Classys, Cluederm, and SKEDERM brands. CLASSYS serves a broad client base, including clinics, hospitals, and beauty salons. The company was founded in 2007 and is headquartered in Seoul, South Korea.
IPO date
Apr 03, 2015
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT